A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne

Universitatsklinik fuer Dermatologie, Bern

Universitats-Kinderspital Zurich, Zurich

ISA - Interdisciplinary Study Association GmbH, Berlin

DiSSal Sezione di Dermatologia Az. Ospedaliera Universitaria, Genova

Virginia Clinical Research, Inc, Norfolk

Universitatsklinikum Schleswig-Holstein, Campus Lubeck, Lübeck

M3-Wake Research, Inc., Raleigh

Barbara Rewerska Diamond Clinic, Krakow

Park Avenue Dermatology, Orange Park

Lenus Research & Medical Group, LLC, Sweetwater

ForCare Clinical Research, Tampa

DS Research, Louisville

Fachklinik Bad Bentheim, Fachbereich Dermatologie und Allergologie, Dermatologische Ambulanz, Bad Bentheim

Universitatsklinikum Bonn, Bonn

Universitaetsklinikum Frankfurt, Frankfurt am Main

UOSD Dermatologia Gen. ed Oncologica DU, PO San Salvatore, L’Aquila

Dermatology Trial Associates, Bryant

Arlington Research Center, Inc., Arlington

Klinikum der Universitat Munchen, München

Tanner Clinic, Layton

California Dermatology & Clinical Research Institute, Encinitas

Ospedale San Pietro Fatebenefratelli, Roma

Azienda Ospedaliero - Universitaria Policlinico Tor Vergata, Roma

Silmedic sp. z o.o, Katowice

Krakowskie Centrum Medyczne sp. z o.o., Krakow

Klinika Ambroziak Sp. z O. O., Warsaw

ROYALDERM Agnieszka Nawrocka, Warsaw

Barn och Ungdomskliniken, Örebro

Avdelningen for Kliniska Provningar, Örebro

Rame Medical Ltd, Penntorr Health, Torpoint

NHS Tayside, Ninewells Hospital and Medical School, Dundee